AstraZeneca PLC announced that Non-Executive Directors Geneviève Berger and Graham Chipchase intend to retire from the Board at the conclusion of the Company's Annual General Meeting on 30 April 2021. By that date, each will have served on the Board for nine years. The company also announced that effective 1 March 2021: Philip Broadley will succeed Graham Chipchase as senior independent Non-Executive Director; and Michel Demaré will become a member of the Nomination and Governance Committee. In addition, the company confirmed that Nazneen Rahman succeeded Geneviève Berger as the Board member with responsibility for overseeing sustainability matters on behalf of the Board on 1 January 2021.